255 related articles for article (PubMed ID: 26199015)
1. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
[TBL] [Abstract][Full Text] [Related]
2. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.
Arora S; Ranade AR; Tran NL; Nasser S; Sridhar S; Korn RL; Ross JT; Dhruv H; Foss KM; Sibenaller Z; Ryken T; Gotway MB; Kim S; Weiss GJ
Int J Cancer; 2011 Dec; 129(11):2621-31. PubMed ID: 21448905
[TBL] [Abstract][Full Text] [Related]
4. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract][Full Text] [Related]
5. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis.
Byeon S; Ham JS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Med Oncol; 2016 Aug; 33(8):97. PubMed ID: 27447711
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospective clinical study.
Liu S; Qiu B; Chen L; Wang F; Liang Y; Cai P; Zhang L; Chen Z; Liu S; Liu M; Liu H
Radiat Oncol; 2015 May; 10():118. PubMed ID: 26014133
[TBL] [Abstract][Full Text] [Related]
8. The features and prognostic impact of extracranial metastases in patients with epidermal growth factor receptor-mutant lung adenocarcinoma.
Bi J; Han G; Wei X; Pi G; Zhang Y; Li Y; Wang M; Hu D; Zhen W
J Cancer Res Ther; 2018; 14(4):799-806. PubMed ID: 29970656
[TBL] [Abstract][Full Text] [Related]
9. A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?
Han G; Bi J; Tan W; Wei X; Wang X; Ying X; Guo X; Zhou X; Hu D; Zhen W
Oncotarget; 2016 Aug; 7(35):56998-57010. PubMed ID: 27486770
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
[TBL] [Abstract][Full Text] [Related]
11. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.
Sun D; Li X; Ma M; Liu J; Xu Y; Ye L; Hou H; Wang C; Li X; Jiang Y
Jpn J Clin Oncol; 2015 May; 45(5):464-73. PubMed ID: 25646356
[TBL] [Abstract][Full Text] [Related]
12. Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer.
Yuan R; Yamada A; Weber B; Ho C
J Neurooncol; 2016 May; 127(3):525-33. PubMed ID: 26780337
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
Baek MY; Ahn HK; Park KR; Park HS; Kang SM; Park I; Kim YS; Hong J; Sym SJ; Park J; Lee JH; Shin DB; Cho EK
Korean J Intern Med; 2018 Jan; 33(1):168-175. PubMed ID: 27093978
[TBL] [Abstract][Full Text] [Related]
14. The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma.
Li B; Sun SZ; Yang M; Shi JL; Xu W; Wang XF; Song MM; Chen HM
J Neurooncol; 2015 Aug; 124(1):79-85. PubMed ID: 26050023
[TBL] [Abstract][Full Text] [Related]
15. Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status.
Li H; Wang W; Jia H; Lian J; Cao J; Zhang X; Song X; Jia S; Li Z; Cao X; Zhou W; Han S; Yang W; Xi Y; Lian S
Thorac Cancer; 2017 Sep; 8(5):436-442. PubMed ID: 28597503
[TBL] [Abstract][Full Text] [Related]
16. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
[TBL] [Abstract][Full Text] [Related]
17. Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
Zhang Q; Zhang X; Yan H; Jiang B; Xu C; Yang J; Chen Z; Su J; Wu YL; Zhou Q
Thorac Cancer; 2016 Nov; 7(6):648-654. PubMed ID: 27755835
[TBL] [Abstract][Full Text] [Related]
18. The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.
Tang Y; Fang W; Zhang Y; Hong S; Kang S; Yan Y; Chen N; Zhan J; He X; Qin T; Li G; Tang W; Peng P; Zhang L
Oncotarget; 2015 Jun; 6(16):14209-19. PubMed ID: 25895031
[TBL] [Abstract][Full Text] [Related]
19. Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms.
Ando T; Kage H; Saito M; Amano Y; Goto Y; Nakajima J; Nagase T
Int J Clin Oncol; 2018 Aug; 23(4):641-646. PubMed ID: 29484515
[TBL] [Abstract][Full Text] [Related]
20. Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
Sadoyama S; Sekine A; Satoh H; Iwasawa T; Kato T; Ikeda S; Sata M; Baba T; Tabata E; Minami Y; Nemoto K; Hayashihara K; Saito T; Okudela K; Ohashi K; Tajiri M; Ogura T
Clin Lung Cancer; 2018 Jan; 19(1):e29-e36. PubMed ID: 28669848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]